News
As more people take GLP-1 medications for weight loss, dietitians are seeing their appointments booked out for months.
Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a ...
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...
WASHINGTON, May 1, 2025 /PRNewswire/ -- With mounting evidence that an infodemic of disinformation about GLP-1 weight loss medicines has become America's second obesity crisis, the National ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results